InflaRx NV IFRX

Healthcare Biotechnology

Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.

NDAQ:IFRX - Post by User

InflaRx NV

Bullboard Posts

Next >>

Post by coolfooldumbguyon Jun 05, 2019 10:45am

101 Views

Post# 29799829

it's a buy today for me

bought in at $3.57 per share,seems to be oversold to me,watching the technicals for this one,german biopharma company with a good cash position,so glta.

Bullboard Posts

Next >>

Now trading on the TSX Venture Exchange: Kootenay Resources Inc.